article thumbnail

How combining datasets from multiple sources can inform and improve commercial strategies

Fierce BioTech

But despite the supportive landscape for rare disease therapies, pharma companies still struggle to launch on time, if at all. But despite the supportive landscape for rare disease therapies, pharma companies still struggle to launch on time, if at all.

article thumbnail

Streamlining Compliance: Outsourcing combined services and technology in pharmacovigilance and regulatory affairs

Fierce BioTech

Streamlining Compliance: Outsourcing combined services and technology in pharmacovigilance and regulatory affairs Biotech and pharma companies are already tapping into the benefits of outsourcing. Download now to learn more. Download now to learn more. Download now to learn more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medicaid and Government Pricing Congress

Drug Channels

Gain timely, up-to-the-minute insights on: CMS’ Proposed Rule 340B Program State Price Transparency Value-Based Contracts Dispute Resolution Bona Fide Service Fees Class of Trade FSS Contracts State Invoicing Policy Initiatives Election Implications And many other critical topics.

article thumbnail

Survey Sheds Light on Current Trends & Opportunities in Site and Patient Recruitment

PPD

Data from the survey has produced enlightening insights about the priorities of both large and small/mid-size pharma companies that can be used to guide business decisions. DOWNLOAD OUR REPORT The post Survey Sheds Light on Current Trends & Opportunities in Site and Patient Recruitment appeared first on PPD Inc.

article thumbnail

Nearly half of supply chain leaders are experiencing drug shortages and disruptions due to pandemic and AI challenge aims to restart economies after lockdowns

The Pharma Data

Pharma leaders fear extreme vulnerability in end-to-end supply chain as pandemic continues, according to global survey. Explore how pharma companies and industry leaders can reset for growth in the lab beyond coronavirus in Pharma IQ ’s fourth annual edition of Smart Lab Digital. Download a copy of the report here.

article thumbnail

Informa Connect’s Access USA

Drug Channels

Just choose your preferred event and prepare to walk away inspired and armed with the knowledge necessary to drive patient access forward. Which event is for you?

article thumbnail

Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…

The Pharma Data

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Source link.